These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34998647)

  • 1. Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma.
    Kunmongkolwut S; Chaisuparat R
    Int J Oral Maxillofac Surg; 2022 Aug; 51(8):1034-1042. PubMed ID: 34998647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Study of
    Kokubun K; Yamamoto K; Akashi Y; Chujo T; Nakajima K; Matsuzaka K
    Int J Surg Pathol; 2022 Jun; 30(4):378-384. PubMed ID: 34994576
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.
    do Canto AM; da Silva Marcelino BMR; Schussel JL; Wastner BF; Sassi LM; Corrêa L; de Freitas RR; Hasséus B; Kjeller G; Junior CAL; Braz-Silva PH
    Clin Oral Investig; 2019 Feb; 23(2):779-784. PubMed ID: 29855709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-V600E expression correlates with ameloblastoma aggressiveness.
    Fregnani ER; Perez DE; Paes de Almeida O; Fonseca FP; Soares FA; Castro-Junior G; Alves FA
    Histopathology; 2017 Feb; 70(3):473-484. PubMed ID: 27681305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial-mesenchymal transition.
    Oh KY; Cho SD; Yoon HJ; Lee JI; Ahn SH; Hong SD
    J Oral Pathol Med; 2019 May; 48(5):413-420. PubMed ID: 30889301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas.
    Lapthanasupkul P; Laosuk T; Ruangvejvorachai P; Aittiwarapoj A; Kitkumthorn N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Nov; 132(5):e180-e185. PubMed ID: 32665205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of BRAF V600E mutation in Iranian population ameloblastomas.
    Derakhshan S; Aminishakib P; Karimi A; Saffar H; Abdollahi A; Mohammadpour H; Kharazi Fard MJ; Memarha A
    Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e502-e507. PubMed ID: 32388526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It was not possible to detect BRAF V600E mutation in circulating cell-free DNA from patients with ameloblastoma: A diagnostic accuracy study.
    Martins-de-Barros AV; da Costa Araújo FA; Barros AMI; Dos Santos EGF; Barbosa Neto AG; da Silva HAM; de Lima ELS; Muniz MTC; Neves RFSN; de Hollanda Valente RO; de Oliveira E Silva ED; de Vasconcelos Carvalho M
    J Oral Pathol Med; 2024 Apr; 53(4):258-265. PubMed ID: 38494749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population.
    Goes CF; Spadigam A; Dhupar A; Carvalho KM; Cota J; Syed S
    Indian J Pathol Microbiol; 2023; 66(2):246-251. PubMed ID: 37077063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.
    Owosho AA; Ladeji AM; Adebiyi KE; Olajide MA; Okoye ISI; Kehinde T; Nwizu NN; Summersgill KF
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3065-3071. PubMed ID: 33231757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the accuracy of anti-BRAF V600E immunohistochemistry results in ameloblastomas.
    Chang JYF; Lu PH; Tseng CH; Wang YP; Lee JJ; Chiang CP
    J Oral Pathol Med; 2023 Apr; 52(4):342-350. PubMed ID: 36625499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MDM2 Overexpression in Ameloblastomas with
    Tosios KI; Kalogirou EM; Koutlas IG
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical and genetic study of BRAF
    Seki-Soda M; Sano T; Ito K; Yokoo S; Oyama T
    Pathol Int; 2020 Apr; 70(4):224-230. PubMed ID: 31930640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of the BRAF gene reveals new variants and high frequency of the V600E mutation among Iranian ameloblastoma patients.
    Soltani M; Tabatabaiefar MA; Mohsenifar Z; Pourreza MR; Moridnia A; Shariati L; Razavi SM
    J Oral Pathol Med; 2018 Jan; 47(1):86-90. PubMed ID: 28650588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of BRAF-V600E mutation to ameloblastoma metabolism.
    Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E expression in ameloblastomas-A 36-patient cohort from Helsinki University Hospital.
    Kelppe J; Thorén H; Ristimäki A; Haglund C; Sorsa T; Hagström J
    Oral Dis; 2019 May; 25(4):1169-1174. PubMed ID: 30811720
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mamat Yusof MN; Ch'ng ES; Radhiah Abdul Rahman N
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
    Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres.
    Bonacina R; Indini A; Massazza G; Rulli E; Gianatti A; Mandalà M;
    J Clin Pathol; 2022 Aug; 75(8):555-559. PubMed ID: 33827932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameloblastoma with mucous cells: A clinicopathological, BRAF mutation, and MAML2 rearrangement study.
    Xia RH; Zhang CY; Sun JJ; Tian Z; Hu YH; Gu T; Wang LZ; Li J
    Oral Dis; 2020 May; 26(4):805-814. PubMed ID: 31954088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.